Add to ORKGTherapeutic angiogenesis is a novel approach to the treatment of myocardial ischemia based on the use of proangiogenic growth factors to induce the growth of new blood vessels to supply the myocardium at risk. This study was designed to assess the safety and efficacy of a single intrapericardial injection of basic fibroblast growth factor (FGF-2) in a porcine model of chronic myocardial ischemia. Yorkshire pigs underwent ameroid placement around the left circumflex coronary artery. At 3 weeks, animals were randomized to receive a single intrapericardial injection of either saline (n 5 10), 3 mg of heparin (n 5 9), 3 mg of heparin 1 30 m
Background—The present article is a report of our animal experiments and also of the first clinical ...
Human cardiac progenitor cells (hCPC) are considered a good candidate in cell therapy for ischemic h...
Effective delivery of exogenous angiogenic growth factors can provide a new therapy for ischemic dis...
Therapeutic angiogenesis is a novel approach to the treatment of myocardial ischemia based on the us...
myocardium has been shown to be a feasible and effec-tive strategy to improve regional blood flow an...
AbstractObjectives. This study was performed to examine the effect of intracoronary exogenous basic ...
AbstractObjectivesWe sought to improve regional myocardial delivery and subsequent collateral perfus...
BACKGROUND: Intramyocardial injection of vascular endothelial growth factor (VEGF) plasmid DNA was s...
Objective: Treatment of coronary disease by growth factors has become an increasingly used strategy ...
AbstractObjectiveTherapeutic angiogenesis is an alternative method of revascularization for end-stag...
The effect of basic fibroblast growth factor (bFGF) administra-tion on regional myocardial function ...
ObjectivesThis study was designed to determine whether controlled release of basic fibroblast growth...
ObjectivesThe purpose of this study was to investigate whether a novel fibroblast growth factor-2 ge...
ObjectivesThe purpose of this study was to test the ability of insulin-like growth factor (IGF)-1/he...
.Objective: We have shown that basic fibroblast growth factor bFGFrFGF-2 enhances myocardial collate...
Background—The present article is a report of our animal experiments and also of the first clinical ...
Human cardiac progenitor cells (hCPC) are considered a good candidate in cell therapy for ischemic h...
Effective delivery of exogenous angiogenic growth factors can provide a new therapy for ischemic dis...
Therapeutic angiogenesis is a novel approach to the treatment of myocardial ischemia based on the us...
myocardium has been shown to be a feasible and effec-tive strategy to improve regional blood flow an...
AbstractObjectives. This study was performed to examine the effect of intracoronary exogenous basic ...
AbstractObjectivesWe sought to improve regional myocardial delivery and subsequent collateral perfus...
BACKGROUND: Intramyocardial injection of vascular endothelial growth factor (VEGF) plasmid DNA was s...
Objective: Treatment of coronary disease by growth factors has become an increasingly used strategy ...
AbstractObjectiveTherapeutic angiogenesis is an alternative method of revascularization for end-stag...
The effect of basic fibroblast growth factor (bFGF) administra-tion on regional myocardial function ...
ObjectivesThis study was designed to determine whether controlled release of basic fibroblast growth...
ObjectivesThe purpose of this study was to investigate whether a novel fibroblast growth factor-2 ge...
ObjectivesThe purpose of this study was to test the ability of insulin-like growth factor (IGF)-1/he...
.Objective: We have shown that basic fibroblast growth factor bFGFrFGF-2 enhances myocardial collate...
Background—The present article is a report of our animal experiments and also of the first clinical ...
Human cardiac progenitor cells (hCPC) are considered a good candidate in cell therapy for ischemic h...
Effective delivery of exogenous angiogenic growth factors can provide a new therapy for ischemic dis...